New research, led by the University of Southampton, has demonstrated that a nanoscale device, called a memristor, could be the ‘missing link’ in the development of implants that use electrical signals from the brain to help treat medical conditions.
Monitoring neuronal cell activity is fundamental to neuroscience and the development of neuroprosthetics – biomedically engineered devices that are driven by neural activity. However, a persistent problem is the device being able to process the neural data in real-time, which imposes restrictive requirements on bandwidth, energy and computation capacity.
In a new study, published in Nature Communications, the researchers showed that memristors could provide real-time processing of neuronal signals (spiking events) leading to efficient data compression and the potential to develop more precise and affordable neuroprosthetics and bioelectronic medicines.
Memristors are electrical components that limit or regulate the flow of electrical current in a circuit and can remember the amount of charge that was flowing through it and retain the data, even when the power is turned off.
Lead author Isha Gupta, Postgraduate Research Student at the University of Southampton, said: “Our work can significantly contribute towards further enhancing the understanding of neuroscience, developing neuroprosthetics and bio-electronic medicines by building tools essential for interpreting the big data in a more effective way.”
The research team developed a nanoscale Memristive Integrating Sensor (MIS) into which they fed a series of voltage-time samples, which replicated neuronal electrical activity.
Acting like synapses in the brain, the metal-oxide MIS was able to encode and compress (up to 200 times) neuronal spiking activity recorded by multi-electrode arrays. Besides addressing the bandwidth constraints, this approach was also very power efficient – the power needed per recording channel was up to 100 times less when compared to current best practice.
Co-author Dr Themis Prodromakis, Reader in Nanoelectronics and EPSRC Fellow in Electronics and Computer Science at the University of Southampton said: “We are thrilled that we succeeded in demonstrating that these emerging nanoscale devices, despite being rather simple in architecture, possess ultra-rich dynamics that can be harnessed beyond the obvious memory applications to address the fundamental constraints in bandwidth and power that currently prohibit scaling neural interfaces beyond 1,000 recording channels.”
Learn more: ‘Missing link’ found in the development of bioelectronic medicines
The Latest on: Bioelectronic medicines
[google_news title=”” keyword=”bioelectronic medicines” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Bioelectronic medicines
- Vagus nerve activation of the spleen shows promise to treat infections, Feinstein Institutes researchon April 26, 2024 at 12:19 pm
One of the main roles of the spleen is to help the body’s immune system fight infections. The spleen does this through producing and regulating antibodies – antibody production is negatively affected ...
- Bioelectronic chip detects vitamins C and D in saliva in under 20 minuteson April 24, 2024 at 9:39 am
Researchers at the University of São Paulo (USP) in Brazil have developed a bioelectronic chip that simultaneously detects vitamins C and D in body fluids. It is flexible and easy to see and can be ...
- Neuromod startup IVEAcare raises $27.5M, names CEOon April 22, 2024 at 8:17 am
Minneapolis-based neuromodulation technology developer iVEAcare announced today that it raised $27.5 million in a Series A financing round.
- Feinstein Institutes’ Daniel A. Grande Named President-Elect of the International Cartilage Regeneration & Joint Preservation Society (ICRS)on April 18, 2024 at 7:00 am
The International Cartilage Regeneration & Joint Preservation Society (ICRS) has named Daniel A. Grande, PhD, assistant vice president of research services and professor of molecular medicine and ...
- Cognito Therapeutics has positive non-invasive neuromod resultson April 15, 2024 at 10:40 am
Cognito Therapeutics today announced treatment results from an open-label extension study of its Alzheimer's treating neuromodulation system.
- EMulate’s radiofrequency device proves effective in GBM mouse modelson April 15, 2024 at 7:19 am
Mice treated with the device exhibited significantly reduced tumour sizes when compared to the untreated cohort.
- Garden City High School takes home top prize at Feinstein Institutes’ annual science competitionon April 11, 2024 at 5:32 am
In addition, leaders across Northwell shared valuable insight around the issue of accessibility and inclusion, including a keynote address from Chad Bouton, professor at the Feinstein Institutes’ ...
- electroCore Announces the Launch of Truvaga Plus® for General Wellnesson April 7, 2024 at 10:30 pm
ROCKAWAY, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the launch of its ...
- Smartphone App Will Warn When You Need a Restroomon March 25, 2024 at 12:00 pm
"One day, patients will be able to trigger urination, on demand, through their smartphone," Guillermo A. Ameer said.
via Bing News